EPHA4 and breast carcinoma: Similar results were observed in luminal A breast cancer cells including MCF7 and T-47D (Fig. 3d and Supplementary Fig. 7d), suggesting the hRNase 1–EphA4 axis might be a general ligand–receptor relationship across breast cancer subtypes.